There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

Knee cartilage is not designed for high stress loads. People who are overweight or obese are at a higher risk of developing osteoarthritis because of the extra stress on their knee joints, with many ...

Compounded semaglutide: Medication produced by compounded pharmacies instead of the original drug manufacturer (Novo Nordisk, ...

When starting prescription weight loss medications, getting approval from a doctor and insurance is one of the hardest parts.

and the US [for semaglutide]. We may not be the first wave launcher in the US, but we have plans." Natco and Mylan have also ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move could jeopardize the availability of cheaper, generic forms of those drugs ...

Drugmaker Lupin aims to be part of the first wave of generic drugmakers to make GLP-1 receptor agonists products, used to ...

Some patients are using lower-than-recommended dosages of generic weight-loss drugs to slim down while ... and needles ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

The demand for our generic and biosimilar drugs remains stable ... Most of the market has shifted towards semaglutide and ...